|
LSM7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.429990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.590990E-01 |
| Normal-vs-Stage2 |
4.650000E-01 |
| Normal-vs-Stage3 |
9.497900E-02 |
| Normal-vs-Stage4 |
4.576400E-01 |
| Stage1-vs-Stage2 |
8.756800E-01 |
| Stage1-vs-Stage3 |
4.030400E-01 |
| Stage1-vs-Stage4 |
5.504800E-01 |
| Stage2-vs-Stage3 |
5.134000E-01 |
| Stage2-vs-Stage4 |
8.526000E-01 |
| Stage3-vs-Stage4 |
2.478600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.324400E-02 |
| Normal-vs-AfricanAmerican |
8.836200E-01 |
| Normal-vs-Asian |
1.807590E-01 |
| Caucasian-vs-AfricanAmerican |
2.744400E-01 |
| Caucasian-vs-Asian |
9.218800E-01 |
| AfricanAmerican-vs-Asian |
3.090400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.524200E-02 |
| Normal-vs-Female |
2.084800E-01 |
| Male-vs-Female |
3.752400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.791600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.986200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.421800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.676170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.864030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.192600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.445000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.898600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.472400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.780600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.472600E-01 |
| Classical-VS-Follicular |
3.218200E-01 |
| Classical-VS-Other |
3.890400E-01 |
| Classical-VS-Normal |
1.126610E-01 |
| Tall-VS-Follicular |
9.568600E-01 |
| Tall-VS-Other |
2.160000E-01 |
| Tall-VS-Normal |
5.434600E-01 |
| Follicular-VS-Other |
2.705800E-01 |
| Follicular-VS-Normal |
5.117600E-01 |
| Other-VS-Normal |
1.638410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.113000E-01 |
| Normal-vs-N1 |
5.364500E-02 |
| N0-vs-N1 |
3.675000E-01 |
|
|
